Journal of Child Neurology · 2015 · 22 citations · 16 references
Life SciencesNeurologyNeuroscienceAutoimmunityImmunotherapyNeuroimmunologyAutoantibodiesAutoantigensAutoimmune DiseasesAutoimmune Neurological DisordersEncephalitisPediatric NeuroimmunologyAcyclovir TherapyEncephalitis TreatmentHerpes Simplex Virus EncephalitisHerpes Simplex Virus ReactivationImmune-mediated Neurologic SequelaeNeuronal AutoantibodiesNmda ReceptorsViral Encephalitis
Post-herpes simplex virus encephalitis relapses have been recently associated with autoimmunity driven by autoantibodies against N-methyl-d-aspartate (NMDA) receptors. Because it offers different treatment options, determination of this condition is important. Between 2011 and 2014, 7 children with proven diagnosis of herpes simplex virus encephalitis were identified in a university hospital of Istanbul. Two patients had neurologic relapse characterized mainly by movement disorders 2 to 3 weeks after initial encephalitis. The first patient received a second 14 days of acyclovir treatment together with antiepileptic drugs and left with severe neurologic sequelae. The second patient was found to be NMDA receptors antibody positive in the cerebrospinal fluid. She was treated with intravenous immunoglobulin and prednisolone. She showed substantial improvement, gradually regaining lost neurologic abilities. Post-herpes simplex virus encephalitis relapses may frequently be immune-mediated rather than a viral reactivation, particularly in children displaying movement disorders like choreoathetosis. Immunotherapy may provide benefit for this potentially devastating condition, like the case described in this report.
16
Herpes simplex virus encephalitis is a trigger of brain autoimmunity
Thaís Armangué, Frank Leypoldt, Ignacio Málaga et al. · Annals of Neurology · 2013 · 453 citations · Full text
N‐methyl‐<scp>D</scp>‐aspartate receptor antibodies in herpes simplex encephalitis
Carsten Finke, Markus Höltje, Jörg Hofmann et al. · Annals of Neurology · 2012 · 411 citations